These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1721661)

  • 21. [Effectiveness of plasmapheresis on the PF-0.5 blood separator in patients with paraproteinemic hemoblastoses].
    Abdullaev OM; Postnikov AA; Prigozhina TA; Likhovetskaia ZM; Mokeeva RA
    Ter Arkh; 1987; 59(10):77-81. PubMed ID: 2448887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Exercise tolerance in patients with exertion angina pectoris after therapeutic plasmapheresis].
    Sharandak AP; Postnikov AA; Model SV; Timakov AV; Mikhaĭlov AV
    Kardiologiia; 1990 Aug; 30(8):58-60. PubMed ID: 2255146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coagulation, hemostasis, and plasma expanders:a quarter century enigma.
    Alexander B; Odake K; Lawlor D; Swanger M
    Fed Proc; 1975 May; 34(6):1429-40. PubMed ID: 47813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognostic significance of baseline state of platelet aggregation and blood viscosity during gravitational plasmapheresis in patients with angina pectoris].
    Kirichenko LL; Radzevich AE; Koniakhin AIu
    Kardiologiia; 1993; 33(2):53-6. PubMed ID: 8084132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Changes in the hemostatic system indices of patients with chronic kidney failure under the influence of enterosorption and plasmapheresis].
    Neĭmark AI; Iakovets IaV
    Ter Arkh; 1994; 66(8):57-60. PubMed ID: 7985157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes in the hemostatic system in patients with ischemic heart disease after isovolemic hemodilution].
    Liusov VA; Soboleva VN; Katyshkina NI
    Kardiologiia; 1985 Sep; 25(9):63-7. PubMed ID: 4079228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes in the platelet-vascular system of hemostasis in patients with ischemic heart disease and hypertension after the treatment].
    Zadionchenko VS; Kamenker ES; Chikvashvili IA
    Kardiologiia; 1989 Oct; 29(10):51-4. PubMed ID: 2575682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The hemostatic potential of the venous and arterial beds in patients with destabilized ischemic heart disease].
    Netiazhenko VZ; Hutsol LP; Plienova OM
    Lik Sprava; 1999 Jul; (5):32-5. PubMed ID: 10822671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indications of plasmapheresis and selection of different substitution solutions.
    Bambauer R; Jutzler GA; Albrecht D; Keller HE; Kohler M
    Biomater Artif Cells Artif Organs; 1989; 17(1):9-26. PubMed ID: 2775871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hemostatic changes in various clinical courses of influenza].
    Barinov VG; Bogomolov BP; Deviatkin AV; Shvedova LP
    Klin Med (Mosk); 1989 Jun; 67(6):104-7. PubMed ID: 2779142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thrombocyte functional resistance and histamine and serotonin metabolism in ischemic heart disease].
    Pliushkis IuA; Lautsevichus LZ; Murza VA; Moteiunaĭte ES
    Kardiologiia; 1978 Jun; 18(6):48-55. PubMed ID: 672019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of plasmapheresis on platelet hemostatic capacity in healthy voluntary blood donors detected by the platelet function analyzer PFA-100.
    Feuring M; Gutfleisch A; Ganschow A; Richter E; Eichler H; Dempfle CE; Tillmann HC; Schultz A; Wehling M
    Platelets; 2001 Jun; 12(4):236-40. PubMed ID: 11454258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The prognostic significance of changes in the level of natural antibodies to thrombin in stenocardia patients].
    Gavrilov OK; Novozhenova TV; Lekokhmakher SS; Dobashina AN; Fedoseev AN; Miagkova MA
    Klin Med (Mosk); 1992 Jan; 70(1):23-6. PubMed ID: 1608202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experience with small-volume plasmapheresis used in the correction of hemostatic disorders in patients with progressive destructive pulmonary tuberculosis].
    Karpina NL; Kaminskaia GO; Serebrianaia BA; Erokhin VV
    Probl Tuberk Bolezn Legk; 2007; (11):33-7. PubMed ID: 18080532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relation between disorders of the rheological properties of the blood and the system of hemostasis in patients with ischemic heart disease].
    Parfenov AS; Belousov IuB
    Kardiologiia; 1989 Oct; 29(10):47-50. PubMed ID: 2615158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [State of lipid metabolism, platelet aggregation and microcirculation in patients with angina pectoris during plasmapheresis treatment].
    Kirichenko LL; Lekokhmakher SS; Popunova AK; Smirnov VV; Narynskiĭ AK
    Kardiologiia; 1990 Aug; 30(8):10-4. PubMed ID: 2255131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of plasmapheresis in multimodality correction of hemostasis disorders in patients with calculous pyelonephritis].
    Nemark AI; Mazyrko AV; Astakhov IuI
    Ter Arkh; 1989; 61(6):86-8. PubMed ID: 2799724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hemodilution in vitro and parameters of hemostasis].
    Levy G; Mak CC; Nhean H
    Ann Anesthesiol Fr; 1979; 20(9):784-8. PubMed ID: 95470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of dextran on coagulation and hemostasis phenomena].
    Bergentz SE
    Anesth Analg (Paris); 1976; 3(4):573-6. PubMed ID: 1015643
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effectiveness of drug therapy alone or its combination with plasmapheresis in patients with severe angina pectoris].
    Sokolov AV; Kel'man EB; Perepech NB; Tsaí NV
    Klin Med (Mosk); 1997; 75(8):31-3. PubMed ID: 9340434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.